|
|
Volumn 6, Issue 23, 2015, Pages 19336-19337
|
|
Doxycycline: New tricks for an old drug
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DNA DEPENDENT PROTEIN KINASE;
DOXYCYCLINE;
HEAT SHOCK PROTEIN 90;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MITOGEN ACTIVATED PROTEIN KINASE;
STAT3 PROTEIN;
TETRACYCLINE DERIVATIVE;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR FOXM1;
UNCLASSIFIED DRUG;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
ACNE;
ANTIPROLIFERATIVE ACTIVITY;
BREAST CANCER;
CANCER INHIBITION;
DRUG REPOSITIONING;
DRUG TARGETING;
EDITORIAL;
HL 60 CELL LINE;
HUMAN;
INFECTION;
LARGE CELL LYMPHOMA;
MCF 7 CELL LINE;
NEDDYLATION;
NONHODGKIN LYMPHOMA;
NONHUMAN;
PANCREAS ADENOCARCINOMA;
PROTEIN DEGRADATION;
ROSACEA;
SKIN DISEASE;
UBIQUITINATION;
OFF LABEL DRUG USE;
ANTI-BACTERIAL AGENTS;
ANTINEOPLASTIC AGENTS;
DOXYCYCLINE;
HUMANS;
OFF-LABEL USE;
|
|
EID: 84939232035
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.5111 Document Type: Editorial |
|
Times cited : (9)
|
|
References (8)
|
